PCSK9 and familial hypercholesterolemia: Since many familial hypercholesterolemia patients do not reach target LDL-C levels, other medication options are the addition of the cholesterol absorption inhibitor ezetimibe, bile acid sequestrants, and PCSK9-targeting monoclonal antibodies [20].